Putting a price on biotechnology
Article Abstract:
U.S. venture capitalist companies are reluctant to invest in biotechnology companies, as valuing such companies is problematic, due partly to relatively little hard marketing data. Mathematical equations are provided to help in this matter.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2001
User Contributions:
Comment about this article or add new information about this topic:
European patent oppositions and biotechnology
Article Abstract:
The European patent system allows for third parties to challenge a patent after it is granted, separate from a litigation process. The author discusses the specific regulations governing this opposition.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
Internet chat damages biotechnology stocks
Article Abstract:
Ridgefield, NJ-based Biomatrix and Cambridge, MA-based Genzyme have been victimized by defamatory Internet postings. Unspecified financial penalties are under discussion for the three men involved.
Publication Name: Nature Biotechnology
Subject: Business
ISSN: 1087-0156
Year: 2000
User Contributions:
Comment about this article or add new information about this topic:
- Abstracts: Evaluating technological collaborative opportunities: a cognitive modeling perspective. Explaining IJV Survival in a Transitional Economy Through Social Exchange and Knowledge-Based Perspectives
- Abstracts: Influences on consumer use of word-of-mouth recommendation sources. An Integrated Model of Sales Managers' Communication Practices
- Abstracts: Norm violations and the role of marketplace comparisons in positioning brands. The Influence of Cause-Related Marketing on Consumer Choice: Does One Good Turn Deserve Another?
- Abstracts: Transgene escape and transplastomics. Phytodetoxification of TNT by transgenic plants expressing a bacterial nitroreductase